Home Naturally occurring heterocyclic anticancer compounds
Article
Licensed
Unlicensed Requires Authentication

Naturally occurring heterocyclic anticancer compounds

  • Shashi Kiran Misra and Kamla Pathak EMAIL logo
Published/Copyright: October 18, 2021
Become an author with De Gruyter Brill
Submit Manuscript Author Information
Physical Sciences Reviews
From the journal Physical Sciences Reviews Volume 8 Issue 8

Abstract

Naturally occurring heterocyclic scaffolds are key ingredients for the development of various therapeutics employed for biomedical applications. Heterocyclic pharmacophores are widely disseminated and have been befallen in almost all categories of drugs for the alleviation of myriad ailments including diabetes, neurodegenerative, psychiatric, microbial infections, disastrous cancers etc. Countless fused heterocyclic anticancerous templates are reported to display antimetabolite, antioxidant, antiproliferative, cytostatic etc. pharmacological actions via targeting different signaling pathways (cell cycle, PI-3kinase/Akt, p53, caspase extrinsic pathway etc.), overexpressive receptors (EGRF, HER2, EGF, VEGF etc.) and physiological enzymes (topoisomerase I and II, cyclin dependent kinase etc.). A compiled description on various natural sources (plants, microbes, marine) containing anticancer agents comprising heterocyclic ring specified with presence of nitrogen (vincristine, vinblastine, indole-3-carbinol, meridianins, piperine, lamellarins etc.), oxygen (paclitaxel, halichondrin B, quercetin, myricetin, kaempferol etc.) and sulphur atoms (brugine, fucoidan, carrageenan etc.) are displayed here along with their molecular level cytotoxic action and therapeutic applications.

Keywords: antimetabolite; cytotoxic; heterocyclic scaffolds; overexpressive receptors; signal pathways
Corresponding author: Prof. Kamla Pathak, Dean, Faculty of Pharmacy, Uttar Pradesh University of Medical Sciences, Saifai, Etawah, 206130, Uttar Pradesh, India, E-mail:

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Sachdeva, H, Mathur, J, Guleria, A. Indole derivatives as potential anticancer agents: a review. J Chil Chem Soc 2020;65:4900–7. https://doi.org/10.4067/s0717-97072020000204900.Search in Google Scholar

2. Jampilek, J. Heterocycles in medicinal chemistry. Molecules 2019;24:3839. https://doi.org/10.3390/molecules24213839.Search in Google Scholar PubMed PubMed Central

3. Dze, K. Heterocycles, their synthesis and industrial applications: a review. Int J Appl Sci Eng Technol 2020;8:36–56. https://doi.org/10.22214/ijraset.2020.31786.Search in Google Scholar

4. Wang, W, Lei, L, Liu, Z, Wang, H, Meng, Q. Design, synthesis, and biological evaluation of novel nitrogen heterocycle-containing ursolic acid analogs as antitumor agents. Molecules 2019;24:877. https://doi.org/10.3390/molecules24050877.Search in Google Scholar PubMed PubMed Central

5. Lang, DK, Kaur, R, Arora, R, Saini, B, Arora, S. Nitrogen-containing heterocycles as anticancer agents: an overview. Anticancer Agents Med Chem 2020;20:2150–68. https://doi.org/10.2174/1871520620666200705214917.Search in Google Scholar PubMed

6. Kim, YS, Milner, J. Targets for indole-3-carbinol in cancer prevention. J Nutr Biochem 2005;16:65–73. https://doi.org/10.1016/j.jnutbio.2004.10.007.Search in Google Scholar PubMed

7. Patil, R, Patil, SA, Beaman, KD, Patil, SA. Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents, an update (2013–2015). Future Med Chem 2016;8:1291–316. https://doi.org/10.4155/fmc-2016-0047.Search in Google Scholar PubMed

8. Garcia, HH, Brar, GA, Nguyen, DH, Bjeldanes, LF, Firestone, GL. Indole-3-carbinol (I3C) inhibits cyclin-dependent kinase-2 function in human breast cancer cells by regulating the size distribution, associated cyclin E forms, and subcellular localization of the CDK2 protein complex. J Biol Chem 2005;280:8756–64. https://doi.org/10.1074/jbc.m407957200.Search in Google Scholar PubMed

9. Bharate, SB, Yadav, RR, Battula, S, Vishwakarma, RA. Meridianins: marine-derived potent kinase inhibitors. Mini Rev Med Chem 2012;12:618–3. https://doi.org/10.2174/138955712800626728.Search in Google Scholar PubMed

10. Wright, AE, Killday, KB, Chakrabarti, D, Guzman, EA, Harmody, D, McCarthy, PJ, et al.. Dragmacidin G, a bioactive bis-indole alkaloid from a deep-water sponge of the genus Spongosorites. Mar Drugs 2017;15:16. https://doi.org/10.3390/md15010016.Search in Google Scholar PubMed PubMed Central

11. Barrows, LR, Radisky, DC, Copp, BR, Swaffar, DS, Kramer, RA, Warters, RL, et al.. Makaluvamines, marine natural products, are active anti-cancer agents and DNA topo II inhibitors. Anticancer Drug Des 1993;8:333–47.Search in Google Scholar

12. Matsumoto, SS, Haughey, HM, Schmehl, DM, Venables, DA, Ireland, CM, Holden, JA, et al.. Makaluvamines vary in ability to induce dosedependent DNA cleavage via topoisomerase II interaction. Anti Canc Drugs 1999;10:39–46. https://doi.org/10.1097/00001813-199901000-00006.Search in Google Scholar PubMed

13. Andersen, RJ, Faulkner, DJ, Cun-heng, H, van Duyne, GD, Clardy, J. Metabolites of the marine prosobranch mollusk Lamellaria sp. J Am Chem Soc 1985;107:5492–5. https://doi.org/10.1021/ja00305a027.Search in Google Scholar

14. Urban, S, Butler, MS, Capon, RJ. Lamellarins O and P: new aromatic metabolites for the Australian marine sponge Dendrilla cactos. Aust J Chem 1994;47:1919–24. https://doi.org/10.1071/ch9941919.Search in Google Scholar

15. Facompré, M, Tardy, C, Bal-Mahieu, C, Colson, P, Perez, C, Manzanares, I, et al.. Lamellarin D: a novel potent inhibitor of topoisomerase I. Cancer Res 2003;63:7392–9.Search in Google Scholar

16. Vanhuyse, M, Kluza, J, Tardy, C, Otero, G, Cuevas, C, Bailly, C, et al.. Lamellarin D: a novel pro-apoptotic agent from marine origin insensitive to P-glycoprotein-mediated drug efflux. Canc Lett 2005;221:165–75. https://doi.org/10.1016/j.canlet.2004.09.022.Search in Google Scholar PubMed

17. Ganjoo, KN, Patel, SR. Trabectedin: an anticancer drug from the sea. Expet Opin Pharmacother 2009;10:2735–43. https://doi.org/10.1517/14656560903277236.Search in Google Scholar PubMed

18. Monk, BJ, Lorusso, D, Italiano, A, Kaye, SB, Aracil, M, Tanović, A, et al.. Trabectedin as a chemotherapy option for patients with BRCA deficiency. Canc Treat Rev 2016;50:175–82. https://doi.org/10.1016/j.ctrv.2016.09.009.Search in Google Scholar PubMed

19. Trabectedin: ecteinascidin 743, ecteinascidin-743, ET 743, ET-743, NSC 684766. Drugs R D 2006;7:317–28. https://doi.org/10.2165/00126839-200607050-00005.Search in Google Scholar PubMed

20. Zheng, J, Zhou, Y, Li, Y, Xu, DP, Li, S, Li, HB. Spices for prevention and treatment of cancers. Nutrients 2016;8:495. https://doi.org/10.3390/nu8080495.Search in Google Scholar PubMed PubMed Central

21. Gorgani, L, Mohammadi, M, Najafpour, GD, Nikzad, M. Piperine-the bioactive compound of black pepper: from isolation to medicinal formulations. Compr Rev Food Sci Food Saf 2007;16:124–40.10.1111/1541-4337.12246Search in Google Scholar

22. Rafiq, RA, Ganai, BA, Tasduq, SA. Piperine promotes ultraviolet (UV)-B-induced cell death in B16F10 mouse melanoma cells through modulation of major regulators of cell survival. RSC Adv 2015;5:11884–94. https://doi.org/10.1039/c4ra12860e.Search in Google Scholar

23. Soutar, DA, Doucette, CD, Liwski, RS, Hoskin, DW. Piperine, a pungent alkaloid from black pepper, inhibits B lymphocyte activation and effector functions. Phytother Res 2017;31:466–74. https://doi.org/10.1002/ptr.5772.Search in Google Scholar PubMed

24. Rodgers, G, Doucette, CD, Soutar, DA, Liwski, RS, Hoskin, DW. Piperine impairs the migration and T cell-activating function of dendritic cells. Toxicol Lett 2016;242:23–33. https://doi.org/10.1016/j.toxlet.2015.11.025.Search in Google Scholar PubMed

25. Manayi, A, Nabavi, SM, Setzer, WN, Jafari, S. Piperine as a potential anti-cancer agent: a review on preclinical studies. Curr Med Chem 2018;25:4918–28. https://doi.org/10.2174/0929867324666170523120656.Search in Google Scholar PubMed

26. Lai, LH, Fu, QH, Liu, Y, Jiang, K, Guo, QM, Chen, QY, et al.. Piperine suppresses tumor growth and metastasis in vitro and in vivo in a 4T1 murine breast cancer model. Acta Pharmacol Sin 2012;33:523–30. https://doi.org/10.1038/aps.2011.209.Search in Google Scholar PubMed PubMed Central

27. Samykutty, A, Shetty, AV, Dakshinamoorthy, G, Bartik, MM, Johnson, GL, Webb, B, et al.. Piperine, a bioactive component of pepper spice exerts therapeutic effects on androgen dependent and androgen independent prostate Cancer cells. PLoS One 2013;8:e65889. https://doi.org/10.1371/journal.pone.0065889.Search in Google Scholar PubMed PubMed Central

28. Damanhouri, ZA, Ahmad, A. A review on therapeutic potential of Piper nigrum L. (black pepper): the king of spices. Med Aromatic Plants 2014;3:161. https://doi.org/10.4172/2167-0412.1000161.Search in Google Scholar

29. Vavrecková, C, Gawlik, I, Müller, K. Benzophenanthridine alkaloids of Chelidonium majus; I. Inhibition of 5- and 12-lipoxygenase by a non-redox mechanism. Planta Med 1996;62:397–401. https://doi.org/10.1055/s-2006-957924.Search in Google Scholar PubMed

30. Kim, S, Lee, TJ, Leem, J, Kyeong, SC, Park, JW, Taeg, KK. Sanguinarine-induced apoptosis: generation of ROS, down-regulation of Bcl-2, c-FLIP, and synergy with TRAIL. J Cell Biochem 2008;104:895–907. https://doi.org/10.1002/jcb.21672.Search in Google Scholar PubMed

31. Debiton, E, Madelmont, JC, Legault, J, Barthomeuf, C. Sanguinarine-induced apoptosis is associated with early and severe cellular glutathione depletion. Canc Chemother Pharmacol 2003;51:474–82. https://doi.org/10.1007/s00280-003-0609-9.Search in Google Scholar PubMed

32. Vogt, AA, Tamewitz, A, Skoko, J, Sikorski, RP, Giuliano, KA, Lazo, JS. The benzo[c]phenanthridine alkaloid, sanguinarine, is a selective, cell-active inhibitor of mitogenactivated protein kinase phosphatase-1. J Biol Chem 2005;280:19078–86. https://doi.org/10.1074/jbc.m501467200.Search in Google Scholar PubMed

33. Chaturvedi, MM, Kumar, A, Darnay, BG, GBN, C, Agarwal, S, Aggarwal, BB. Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-κB activation, IκBα phosphorylation, and degradation. J Biol Chem 1997;272:30129–34. https://doi.org/10.1074/jbc.272.48.30129.Search in Google Scholar PubMed

34. Ji, YB. Active ingredients of traditional Chinese medicine: pharmacology and application. USA: People’s Medical Publishing Hourse Cp, Ltd.; 2011.Search in Google Scholar

35. Kuo, PL, Lin, CC. Tetrandrine-induced cell cycle arrest and apoptosis inHep G2 cells. Life Sci 2003;73:243–52. https://doi.org/10.1016/s0024-3205(03)00266-2.Search in Google Scholar PubMed

36. Meng, LH, Zhang, H, Hayward, L, Takemura, H, Shao, RG, Pommier, Y. Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G 1-S-specific cyclin-dependent kinases and by inducing p53 and p21Cip1. Cancer Res 2004;64:9086–92. https://doi.org/10.1158/0008-5472.can-04-0313.Search in Google Scholar

37. Ng, LT, Chiang, LC, Lin, YT, Lin, CC. Antiproliferative and apoptotic effects of tetrandrine on different human hepatoma cell lines. Am J Chin Med 2006;34:125–35. https://doi.org/10.1142/s0192415x06003692.Search in Google Scholar PubMed

38. Lee, SH, Son, JK, Jeong, BS, Jeong, TC, Chang, HW, Lee, ES, et al.. Progress in the studies on rutaecarpine. Molecules 2008;13:272–300. https://doi.org/10.3390/molecules13020272.Search in Google Scholar PubMed PubMed Central

39. Zhang, Y, Wu, LJ, Tashiro, S, Onodera, S, Ikejima, T. Intracellular regulation of evodiamineinduced A375-S2 cell death. Biol Pharm Bull 2003;26:1543–7. https://doi.org/10.1248/bpb.26.1543.Search in Google Scholar PubMed

40. Zhang, Y, Wu, LJ, Tashiro, S, Onodera, S, Ikejima, T. Evodiamine induces tumor cell death through two different pathways: apoptosis and necrosis. Acta Pharmacol Sin 2004;25:83–9.Search in Google Scholar

41. Wang, C, Wang, MW, Tashiro, S, Onodera, S, Ikejima, T. Roles of SIRT1 and phosphoinositide 3-OH kinase/protein kinase C pathways in evodiamine-induced human melanoma A375-S2 cell death. J Pharmacol Sci 2005;97:494–500. https://doi.org/10.1254/jphs.fpj04055x.Search in Google Scholar PubMed

42. Yang, J, Wu, LJ, Tashino, SI, Onodera, S, Ikejima, T. Reactive oxygen species and nitric oxide regulate mitochondriadependent apoptosis and autophagy in evodiamine-treated human cervix carcinoma HeLa cells. Free Radic Res 2008;42:492–504. https://doi.org/10.1080/10715760802112791.Search in Google Scholar PubMed

43. Pommier, Y. Topoisomerase I inhibitors: camptothecins and beyond. Nat Rev Canc 2006;6:789–802. https://doi.org/10.1038/nrc1977.Search in Google Scholar PubMed

44. Kacprzak, KM. Chemistry and biology of camptothecin and its derivatives. In: Ramawat, K, Mérillon, JM, editors. Natural products. Berlin, Heidelberg: Springer; 2013.10.1007/978-3-642-22144-6_26Search in Google Scholar

45. Tan, W, Li, Y, Chen, M, Wang, Y. Berberine hydrochloride: anticancer activity and nanoparticulate delivery system. Int J Nanomed 2011;6:1773–7. https://doi.org/10.2147/ijn.s22683.Search in Google Scholar

46. Liu, X, Li, G, Zhu, H, Huang, L, Liu, Y, Ma, C, et al.. Beneficial effect of berberine on hepatic insulin resistance in diabetic hamsters possibly involves in SREBPs, LXRα and PPARα transcriptional programs. Endocr J 2010;57:881–93. https://doi.org/10.1507/endocrj.k10e-043.Search in Google Scholar PubMed

47. Lee, IA, Hyun, YJ, Kim, DH. Berberine ameliorates TNBS-induced colitis by inhibiting lipid peroxidation, enterobacterial growth and NF-κB activation. Eur J Pharmacol 2010;648:162–70. https://doi.org/10.1016/j.ejphar.2010.08.046.Search in Google Scholar PubMed

48. Katiyar, SK, Meeran, SM, Katiyar, N, Akhtar, S. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Mol Carcinog 2009;48:24–37. https://doi.org/10.1002/mc.20453.Search in Google Scholar PubMed

49. Meeran, SM, Katiyar, S, Katiyar, SK. Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation. Toxicol Appl Pharmacol 2008;229:33–43. https://doi.org/10.1016/j.taap.2007.12.027.Search in Google Scholar PubMed

50. Wang, N, Feng, Y, Zhu, M, Tsang, CM, Man, K, Tong, Y, et al.. Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism. J Cell Biochem 2010;111:1426–36. https://doi.org/10.1002/jcb.22869.Search in Google Scholar PubMed

51. Kulkarni, YA, Garud, MS, Oza, MJ, Gaikwad, AB. Chapter 28 – Biomarkers of multiple sclerosis and their modulation by natural products. In: Watson, RR, Killgore, WDS, editors. Nutrition and lifestyle in neurological autoimmune diseases. USA: Academic Press; 2017:275–84 pp.10.1016/B978-0-12-805298-3.00028-1Search in Google Scholar

52. Zhang, H, Chen, L, Sun, X, Yang, Q, Wan, L, Cheng, G. Matrine: a promising natural product with various pharmacological activities. Front Pharmacol 2020;11:588. https://doi.org/10.3389/fphar.2020.00588.Search in Google Scholar PubMed PubMed Central

53. Kragh Larsen, A, Grondard, L, Couprie, J, Bernard, D, Comoe, L, Jardillier, JC, et al.. The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and II. Biochem Pharmacol 1993;46:1403–12. https://doi.org/10.1016/0006-2952(93)90105-6.Search in Google Scholar PubMed

54. Cao, Z, Yang, P, Zhou, Q. Multiple biological functions and pharmacological effects of lycorine. Sci China Chem 2013;56:1382–91. https://doi.org/10.1007/s11426-013-4967-9.Search in Google Scholar PubMed PubMed Central

55. Cossy, J, Guérinot, A. Chapter five – Natural products containing oxygen heterocycles—synthetic advances between 1990 and 2015. In: Scriven, EFV, Ramsden, CA, editors. Advances in heterocyclic chemistry. USA: Academic Press; 2016, 119:107–42 pp.10.1016/bs.aihch.2016.03.002Search in Google Scholar

56. Weaver, BA. How taxol/paclitaxel kills cancer cells. Mol Biol Cell 2014;2518:2677–81. https://doi.org/10.1091/mbc.e14-04-0916.Search in Google Scholar PubMed PubMed Central

57. Foglietta, F, Spagnoli, GC, Muraro, MG, Ballestri, M, Guerrini, A, Ferroni, C, et al.. Anticancer activity of paclitaxel-loaded keratin nanoparticles in two-dimensional and perfused three-dimensional breast cancer models. Int J Nanomed 2018;13:4847–67. https://doi.org/10.2147/ijn.s159942.Search in Google Scholar PubMed PubMed Central

58. Fanciullino, R, Ciccolini, J, Milano, G. Challenges, expectations and limits for nanoparticles-based therapeutics in cancer: a focus on nano-albumin-bound drugs. Crit Rev Oncol Hematol 2013;88:504–13. https://doi.org/10.1016/j.critrevonc.2013.06.010.Search in Google Scholar PubMed

59. Foley, EA, Kapoor, TM. Microtubule attachment and spindle assembly checkpoint signaling at the kinetochore. Nat Rev Mol Cell Biol 2013;14:25–37. https://doi.org/10.1038/nrm3494.Search in Google Scholar PubMed PubMed Central

60. Ojedalopez, MA, Needleman, DJ, Song, C, Ginsburg, A, Kohl, PA, Li, Y, et al.. Transformation of taxol-stabilized microtubules into inverted tubulin tubules triggered by a tubulin conformation switch. Nat Mater 2014;13:195–203. https://doi.org/10.1038/nmat3858.Search in Google Scholar PubMed PubMed Central

61. Liu, QA, Zheng, JJ, Gu, YC, Wang, CY, Shao, CL. Chapter 7 – The chemistry and bioactivity of macrolides from marine microorganisms. In: Rahman, AU, editor. Studies in natural products chemistry. USA: Elsevier; 2015, 44:353–401 pp.10.1016/B978-0-444-63460-3.00007-9Search in Google Scholar

62. Hamel, E. Natural products which interact with tubulin in the Vinca domain: maytansine, rhizoxin, phomopsin A, dolastatins 10 and 15 and halichondrin B. Pharmacol Ther 1992;55:31–51. https://doi.org/10.1016/0163-7258(92)90028-x.Search in Google Scholar PubMed

63. Jordan, MA, Kamath, K, Manna, T, Okouneva, T, Miller, HP, Davis, C, et al.. The primary antimitotic mechanism of action of the synthetic halichondrin E7389 is suppression of microtubule growth. Littlefield and Leslie Wilson. Mol Canc Therapeut 2005;4:1086–95. https://doi.org/10.1158/1535-7163.mct-04-0345.Search in Google Scholar

64. Jordan, MA, Wilson, L. Microtubules as a target for anticancer drugs. Nat Rev Canc 2004;4:253–65. https://doi.org/10.1038/nrc1317.Search in Google Scholar PubMed

65. Metodiewa, D, Jaiswal, AK, Cenas, N, Dickancaite, E, Segura-Aguilar, J. Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radical Biol Med 1999;26:107–16. https://doi.org/10.1016/s0891-5849(98)00167-1.Search in Google Scholar PubMed

66. Boots, AW, Haenen, GR, Bast, A. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 2008;585:325–37. https://doi.org/10.1016/j.ejphar.2008.03.008.Search in Google Scholar PubMed

67. Panche, AN, Diwan, AD, Chandra, SR. Flavonoids: an overview. J Nutr Sci 2016;5:e47. https://doi.org/10.1017/jns.2016.41.Search in Google Scholar PubMed PubMed Central

68. Khan, F, Niaz, K, Maqbool, F, Ismail Hassan, F, Abdollahi, M, Nagulapalli Venkata, KC, et al.. Molecular targets underlying the anticancer effects of quercetin: an update. Nutrients 2016;8:529. https://doi.org/10.3390/nu8090529.Search in Google Scholar PubMed PubMed Central

69. Spagnuolo, C, Russo, M, Bilotto, S, Tedesco, I, Laratta, B, Russo, GL. Dietary polyphenols in cancer prevention: the example of the flavonoid quercetin in leukemia. Ann N Y Acad Sci 2012;1259:95–103. https://doi.org/10.1111/j.1749-6632.2012.06599.x.Search in Google Scholar PubMed

70. Yoshida, M, Yamamoto, M, Nikaido, T. Quercetin arrests human leukemic T-cells in late G1 phase of the cell cycle. Cancer Res 1992;52:6676–81.Search in Google Scholar

71. Zhang, Q, Zhao, XH, Wang, ZJ. Flavones and flavonols exert cytotoxic effects on a human oesophageal adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing apoptosis. Food Chem Toxicol 2008;46:2042–53. https://doi.org/10.1016/j.fct.2008.01.049.Search in Google Scholar PubMed

72. Richter, M, Ebermann, R, Marian, B. Quercetin-induced apoptosis in colorectal tumor cells: possible role of EGF receptor signaling. Nutr Canc 1999;34:88–99. https://doi.org/10.1207/s15327914nc340113.Search in Google Scholar PubMed

73. Lau-Cam, CA, Chan, HH. Flavonoids from Comptonia peregrine. Phytochemistry 1973;12:1829. https://doi.org/10.1016/0031-9422(73)80420-0.Search in Google Scholar

74. Perkin, AG, Hummel, JJ. LXXVI-The colouring principle contained in the bark of Myrica nagi Part I. J Chem Soc Trans 1896;69:1287–94. https://doi.org/10.1039/ct8966901287.Search in Google Scholar

75. Lin, GB, Xie, Y, Li, GW. Research advances of myricetin. J Int Pharm Res 2012;39:483–7.Search in Google Scholar

76. López-Lázaro, M, Willmore, E, Austin, CA. The dietary flavonoids myricetin and fisetin act as dual inhibitors of DNA topoisomerases I and II in cells. Mutat Res 2010;696:41–7. https://doi.org/10.1016/j.mrgentox.2009.12.010.Search in Google Scholar PubMed

77. Lee, KW, Kang, NJ, Rogozin, EA, Kim, HG, Cho, YY, Bode, AM, et al.. Myricetin is a novel natural inhibitor of neoplastic cell transformation and MEK1. Carcinogenesis 2007;28:1918–27. https://doi.org/10.1093/carcin/bgm110.Search in Google Scholar PubMed

78. Anderson, D, Dobrzyńska, MM, Yu, TW. Modulating effects of Silymarin and myricetin on food mutagens and doxorubicin in assays with different genetic endpoints. J Environ Pathol Toxicol Oncol 1997;16:313–27.Search in Google Scholar

79. Labbé, D, Provençal, M, Lamy, S, Boivin, D, Gingras, D, Béliveau, R. The flavonols quercetin, kaempferol, and myricetin inhibit hepatocyte growth factor-induced medulloblastoma cell migration. J Nutr 2009;139:646–52. https://doi.org/10.3945/jn.108.102616.Search in Google Scholar PubMed

80. Ren, J, Lu, Y, Qian, Y, Chen, B, Wu, T, Ji, G. Recent progress regarding kaempferol for the treatment of various diseases (Review). Exp Ther Med 2019;18:2759–76. https://doi.org/10.3892/etm.2019.7886.Search in Google Scholar PubMed PubMed Central

81. Calderón-Montaño, JM, Burgos-Morón, E, Pérez-Guerrero, C, López-Lázaro, M. A review on the dietary flavonoid kaempferol. Mini Rev Med Chem 2011;11:298–344. https://doi.org/10.2174/138955711795305335.Search in Google Scholar PubMed

82. Hegde, A, Bhatia, M. Hydrogen sulfide in inflammation: friend or foe? Inflamm Allergy Drug Targets 2011;10:118–22. https://doi.org/10.2174/187152811794776268.Search in Google Scholar PubMed

83. Ren, J, Lu, Y, Qian, Y, Chen, B, Wu, T, Ji, G. Recent progress regarding kaempferol for the treatment of various diseases (Review). Exp Ther Med 2019;18:2759–76. https://doi.org/10.3892/etm.2019.7886.Search in Google Scholar PubMed PubMed Central

84. Chen, AY, Chen, YC. A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention. Food Chem 2013;138:2099–107. https://doi.org/10.1016/j.foodchem.2012.11.139.Search in Google Scholar PubMed PubMed Central

85. Yao, S, Wang, X, Li, C, Zhao, T, Jin, H, Fang, W. Kaempferol inhibits cell proliferation and glycolysis in esophagus squamous cell carcinoma via targeting EGFR signaling pathway. Tumour Biol 2016;37:10247–56. https://doi.org/10.1007/s13277-016-4912-6.Search in Google Scholar PubMed

86. Kim, SH, Hwang, KA, Choi, KC. Treatment with kaempferol suppresses breast cancer cell growth caused by estrogen and triclosan in cellular and xenograft breast cancer models. J Nutr Biochem 2016;28:70–82. https://doi.org/10.1016/j.jnutbio.2015.09.027.Search in Google Scholar PubMed

87. Wu, LY, Lu, HF, Chou, YC, Shih, YL, Bau, DT, Chen, JC, et al.. Kaempferol induces DNA damage and inhibits DNA repair associated protein expressions in human promyelocytic leukemia HL-60 cells. Am J Chin Med 2015;43:365–82. https://doi.org/10.1142/s0192415x1550024x.Search in Google Scholar PubMed

88. Di Carlo, G, Mascolo, N, Izzo, AA, Capasso, F. Flavonoids: old and new aspects of a class of natural therapeutic drugs. Life Sci 1999;65:337–53. https://doi.org/10.1016/s0024-3205(99)00120-4.Search in Google Scholar PubMed

89. Batovska, DI, Todorova, IT. Trends in utilization of the pharmacological potential of chalcones. Curr Clin Pharmacol 2010;5:1–29. https://doi.org/10.2174/157488410790410579.Search in Google Scholar PubMed

90. Pandey, MK, Sung, B, Ahn, KS, Aggarwal, BB. Butein suppresses constitutive and inducible signal transducer and activator of transcription (STAT) 3 activation and STAT3-regulated gene products through the induction of a protein tyrosine phosphatase SHP-1. Mol Pharmacol 2009;75:525–33. https://doi.org/10.1124/mol.108.052548.Search in Google Scholar PubMed PubMed Central

91. Bordoloi, D, Monisha, J, Roy, NK, Padmavathi, G, Banik, K, Chaudhary, H, et al.. An investigation on the therapeutic potential of butein, a tretrahydroxychalcone against human oral squamous cell carcinoma. Asian Pac J Cancer Prev APJCP 2019;20:3437–46. https://doi.org/10.31557/apjcp.2019.20.11.3437.Search in Google Scholar PubMed PubMed Central

92. Cho, SG, Woo, SM, Ko, SG. Butein suppresses breast cancer growth by reducing a production of intracellular reactive oxygen species. J Exp Clin Canc Res 2014;33:51. https://doi.org/10.1186/1756-9966-33-51.Search in Google Scholar PubMed PubMed Central

93. Park, I, Park, KK, Park, JH, Chung, WY. Isoliquiritigenin induces G2 and M phase arrest by inducing DNA damage and by inhibiting the metaphase/anaphase transition. Canc Lett 2009;277:174–81. https://doi.org/10.1016/j.canlet.2008.12.005.Search in Google Scholar PubMed

94. Zhang, B, Lai, Y, Li, Y, Shu, N, Wang, Z, Wang, Y, et al.. Antineoplastic activity of isoliquiritigenin, a chalcone compound, in androgen-independent human prostate cancer cells linked to G2/M cell cycle arrest and cell apoptosis. Eur J Pharmacol 2018;821:57–67. https://doi.org/10.1016/j.ejphar.2017.12.053.Search in Google Scholar PubMed

95. Chen, C, Shenoy, AK, Padia, R, Fang, D, Jing, Q, Yang P, et al.. Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2′, 4′-Tetrahydroxychalcone. J Exp Clin Canc Res 2018;37:243. https://doi.org/10.1186/s13046-018-0902-4.Search in Google Scholar PubMed PubMed Central

96. Shi, Y, Wu, W, Huo, A, Zhou, W, Jin, X. Isobavachalcone inhibits the proliferation and invasion of tongue squamous cell carcinoma cells. Oncol Lett 2017;14:2852–8. https://doi.org/10.3892/ol.2017.6517.Search in Google Scholar PubMed PubMed Central

97. Li, K, Zheng, Q, Chen, X, Wang, Y, Wang, D, Wang, J. Isobavachalcone induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in human prostate cancer PC-3 cells. Oxid Med Cell Longev 2018;2018. https://doi.org/10.1155/2018/1915828.Search in Google Scholar PubMed PubMed Central

98. Mordente, A, Meucci, E, Silvestrini, A, Martorana, GE, Giardina, B. New developments in anthracycline-induced cardiotoxicity. Curr Med Chem 2009;16:1656–72. https://doi.org/10.2174/092986709788186228.Search in Google Scholar PubMed

99. Tacar, O, Sriamornsak, P, Dass, CR. Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol 2013;65:157–70. https://doi.org/10.1111/j.2042-7158.2012.01567.x.Search in Google Scholar PubMed

100. Omiecinski, CJ, Vanden Heuvel, JP, Perdew, GH, Peters, JM. Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities. Toxicol Sci 2011;120(1 Suppl):S49–75. https://doi.org/10.1093/toxsci/kfq338.Search in Google Scholar PubMed PubMed Central

101. Clive, AO, Jones, HE, Bhatnagar, R, Preston, NJ, Maskell, N. Interventions for the management of malignant pleural effusions: a network meta-analysis. Cochrane Database Syst Rev 2016;2016:CD010529. https://doi.org/10.1002/14651858.CD010529.pub3.Search in Google Scholar PubMed PubMed Central

102. Hecht, SM. Bleomycin: new perspectives on the mechanism of action. J Nat Prod 2000;63:158–68. https://doi.org/10.1021/np990549f.Search in Google Scholar PubMed

103. Sobell, HM. Actinomycin and DNA transcription. Proc Natl Acad Sci USA 1985;82:5328–31. https://doi.org/10.1073/pnas.82.16.5328.Search in Google Scholar PubMed PubMed Central

104. Khatua, S, Nair, CN, Ghosh, K. Immune-mediated thrombocytopenia following dactinomycin therapy in a child with alveolar rhabdomyosarcoma: the unresolved issues. J Pediatr Hematol Oncol 2004;26:777–9. https://doi.org/10.1097/00043426-200411000-00020.Search in Google Scholar PubMed

105. Sithranga Boopathy, N, Kathiresan, K. Anticancer drugs from marine flora: an overview. J Oncol 2010;2010:214186. https://doi.org/10.1155/2010/214186.Search in Google Scholar PubMed PubMed Central

106. Naskar, K, Guha bakshi, DN. Vegetarian patterns of the sundarbans. In: Mangrove swamps of the sundarbans. An ecological perspective. Culcutta, India: Naya Prakash; 1995:27–174 pp.Search in Google Scholar

107. Cotelle, N, Bemier, JL, Catteau, JP, Pommery, J, Wallet, JC, Gaydou, EM. Antioxidant properties of hydroxyl flavones. Free Radical Biol Med 1996;20:35–43. https://doi.org/10.1016/0891-5849(95)02014-4.Search in Google Scholar PubMed

108. Sithranga Boopathy, N, Kathiresan, K. Anticancer drugs from marine flora: an overview. J Oncol 2010;2010:214186. https://doi.org/10.1155/2010/214186.Search in Google Scholar

109. Yi, XX, Deng, JG, Gao, CH, Hou, XT, Li, F, Wang, ZP, et al.. Four new cyclohexylideneacetonitrile derivatives from the hypocotyl of mangrove (Bruguiera gymnorrhiza). Molecules 2015;20:14565–75. https://doi.org/10.3390/molecules200814565.Search in Google Scholar PubMed PubMed Central

110. Yang, H, Zeng, M, Dong, S, Liu, Z, Li, R. Anti-proliferative activity of phlorotannin extracts from brown algae Laminaria japonica Aresch. Chin J Oceanol Limnol 2010;28:122–30. https://doi.org/10.1007/s00343-010-9054-x.Search in Google Scholar

111. Pangestuti, R, Kim, SK. Biological activities and health benefit effects of natural pigments derived from marine algae. J Funct Food 2011;3:255–66. https://doi.org/10.1016/j.jff.2011.07.001.Search in Google Scholar

112. Asai, A, Sugawara, T, Ono, H, Nagao, H. Biotransformation of fucoxanthinol into amarouciaxanthin a in mice and HepG2 cells: formation and cytotoxicity of fucoxanthin metabolites. Drug Metab Dispos 2004;32:205–11. https://doi.org/10.1124/dmd.32.2.205.Search in Google Scholar PubMed

113. Kwon, MJ, Nam, TJ. Porphyran induces apoptosis related signal pathway in AGS gastric cancer cell lines. Life Sci 2006;79:1956–62. https://doi.org/10.1016/j.lfs.2006.06.031.Search in Google Scholar PubMed

114. Zhang, Q, Li, N, Liu, X, Zhao, Z, Li, Z, Xu, Z. The structure of a sulfated galactan from Porphyra haitanensis and its in vivo antioxidant activity. Carbohydr Res 2004;339:105–11. https://doi.org/10.1016/j.carres.2003.09.015.Search in Google Scholar PubMed

115. Moghadamtousi, SZ, Karimian, H, Khanabdali, R, Razavi, M, Firoozinia, M, Zandi, K, et al.. Anticancer and antitumor potential of fucoidan and fucoxanthin, two main metabolites isolated from brown algae. Sci 2014;2014:768323.10.1155/2014/768323Search in Google Scholar

116. Cumashi, A, Ushakova, NA, Preobrazhenskaya, ME, D’Incecco, A, Piccoli, A, Totani, L, et al.. A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. Glycobiology 2007;17:541–52. https://doi.org/10.1093/glycob/cwm014.Search in Google Scholar PubMed

117. Itoh, H, Noda, H, Amano, H, Zhuaug, C, Mizuno, T, Ito, H. Antitumor activity and immunological properties of marine algal polysaccharides, especially fucoidan, prepared from Sargassum thunbergii of Phaeophyceae. Anticancer Res 1993;13:2045–52.Search in Google Scholar

118. Koyanagi, S, Tanigawa, N, Nakagawa, H, Soeda, S, Shimeno, H. Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities. Biochem Pharmacol 2003;65:173–9. https://doi.org/10.1016/s0006-2952(02)01478-8.Search in Google Scholar PubMed

119. Kawamoto, H, Miki, Y, Kimura, T, Tanaka, K, Nakagawa, T, Kawamukai, M, et al.. Effects of fucoidan from Mozuku on human stomach cell lines. Food Sci Technol Res 2006;12:218–22. https://doi.org/10.3136/fstr.12.218.Search in Google Scholar

120. Synytsya, A, Kim, WJ, Kim, SM, Pohl, R, Synytsya, A, Kvasnička, F, et al.. Structure and antitumour activity of fucoidan isolated from sporophyll of Korean brown seaweed Undaria pinnatifida. Carbohydr Polym 2010;81:41–8. https://doi.org/10.1016/j.carbpol.2010.01.052.Search in Google Scholar

121. Alekseyenko, TV, Zhanayeva, SY, Venediktova, AA, Zvyagintseva, TN, Kuznetsova, TA, Besednova, NN, et al.. Antitumor and antimetastatic activity of fucoidan, a sulfated polysaccharide isolated from the Okhotsk sea Fucus evanescens brown alga. Bull Exp Biol Med 2007;143:730–2. https://doi.org/10.1007/s10517-007-0226-4.Search in Google Scholar PubMed

122. Chandrasekaran, R, Bian, W, Okuyama, K. Three-dimensional structure of guaran. Carbohydr Res 1998;312:219–24. https://doi.org/10.1016/s0008-6215(98)00249-3.Search in Google Scholar

123. Necas, J, Bartosikova, L. Carrageenan: a review. Vet Med 2013;58:187–205. https://doi.org/10.17221/6758-vetmed.Search in Google Scholar

124. Haijin, M, Xiaolu, J, Huashi, GA. Carrageenan derived oligosaccharide prepared by enzymatic degradation containing anti-tumor activity. J Appl Phycol 2003;15:297–303. https://doi.org/10.1023/a:1025103530534.10.1023/A:1025103530534Search in Google Scholar

125. Yuan, H, Song, J, Li, X, Li, N, Liu, S. Enhanced immunostimulatory and antitumor activity of different derivatives of Carrageenan oligosaccharides from Kappaphycus striatum. J Appl Phycol 2011;23:59–65. https://doi.org/10.1007/s10811-010-9536-4.Search in Google Scholar

126. Zhou, G, Xin, H, Sheng, W, Sun, Y, Li, Z, Xu, Z. In vivo growth-inhibition of S180 tumor by mixture of 5-Fu and low molecular carrageenan from Chondrus ocellatus. Pharmacol Res 2005;51:153–7. https://doi.org/10.1016/j.phrs.2004.07.003.Search in Google Scholar PubMed

127. Zhou, G, Sheng, W, Yao, W, Wang, C. Effect of low molecular lambda-carrageenan from Chondrus ocellatus on antitumor H-22 activity of 5-Fu. Pharmacol Res 2006;53:129–34. https://doi.org/10.1016/j.phrs.2005.09.009.Search in Google Scholar PubMed

128. Vaddula, B, Tantak, M, Sadana, R, Gonzaleg, MA, Kumar, D. One-pot synthesis and in-vitro anticancer evaluation of 5-(2′-indolyl)thiazoles. Sci Rep 2016;6:23401. https://doi.org/10.1038/srep23401.Search in Google Scholar PubMed PubMed Central

129. Mezencev, R, Galizzi, M, Kutschy, P, Docampo, R. Trypanosoma cruzi: antiproliferative effect of indole phytoalexins on intracellular amastigotes in vitro. Exp Parasitol 2009;122:66–9. https://doi.org/10.1016/j.exppara.2009.01.013.Search in Google Scholar PubMed PubMed Central

130. Smith, BA, Neal, CL, Chetram, M, Vo, B, Mezencev, R, Hinton, C, et al.. The phytoalexin camalexin mediates cytotoxicity towards aggressive prostate cancer cells via reactive oxygen species. J Nat Med 2013;67:607–18. https://doi.org/10.1007/s11418-012-0722-3.Search in Google Scholar PubMed PubMed Central

131. Mezencev, R, Updegrove, T, Kutschy, P, Repovská, M, McDonald, JF. Camalexin induces apoptosis in T-leukemia Jurkat cells by increased concentration of reactive oxygen species and activation of caspase-8 and caspase-9. J Nat Med 2011;65:488–99. https://doi.org/10.1007/s11418-011-0526-x.Search in Google Scholar PubMed

132. Yang, Y, Wang, G, Wu, W, Yao, S, Han, X, He, D, et al.. Camalexin induces apoptosis via the ROS-ER stress-mitochondrial apoptosis pathway in AML cells. Oxid Med Cell Longev 2018;2018:7426950. https://doi.org/10.1155/2018/7426950.Search in Google Scholar PubMed PubMed Central

133. Cheung, KL, Kong, AN. Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention. AAPS J 2010;12:87–97. https://doi.org/10.1208/s12248-009-9162-8.Search in Google Scholar PubMed PubMed Central

134. Gupta, P, Wright, SE, Kim, SH, Srivastava, SK. Phenethyl isothiocyanate: a comprehensive review of anti-cancer mechanisms. Biochim Biophys Acta 2014;1846:405–24. https://doi.org/10.1016/j.bbcan.2014.08.003.Search in Google Scholar PubMed PubMed Central

Published Online: 2021-10-18

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Reviews
  3. Influence of lime (CaO) on low temperature leaching of some types of bauxite from Guinea
  4. Ethnobotanical survey, phytoconstituents and antibacterial investigation of Rapanea melanophloeos (L.) Mez. bark, fruit and leaf extracts
  5. Catalytic properties of supramolecular polymetallated porphyrins
  6. Lignin-based polymers
  7. Bio-based polyhydroxyalkanoates blends and composites
  8. Biodegradable poly(butylene adipate-co-terephthalate) (PBAT)
  9. Repurposing tires – alternate energy source?
  10. Theoretical investigation of the stability, reactivity, and the interaction of methyl-substituted peridinium-based ionic liquids
  11. Polymeric membranes for biomedical applications
  12. Design of locally sourced activated charcoal filter from maize cob for wastewater decontamination: an approach to fight waste with waste
  13. Synthesis of biologically active heterocyclic compounds from allenic and acetylenic nitriles and related compounds
  14. Magnetic measurement methods to probe nanoparticle–matrix interactions
  15. Health and exposure risk assessment of heavy metals in rainwater samples from selected locations in Rivers State, Nigeria
  16. Evaluation of raw, treated and effluent water quality from selected water treatment plants: a case study of Lagos Water Corporation
  17. A chemoinformatic analysis of atoms, scaffolds and functional groups in natural products
  18. Hemicyanine dyes
  19. Thermodynamics of the micellization of quaternary based cationic surfactants in triethanolamine-water media: a conductometry study
  20. Compounds isolated from hexane fraction of Alternanthera brasiliensis show synergistic activity against methicillin resistant Staphylococcus aureus
  21. Internal structures and mechanical properties of magnetic gels and suspensions
  22. SPIONs and magnetic hybrid materials: Synthesis, toxicology and biomedical applications
  23. Magnetic field controlled behavior of magnetic gels studied using particle-based simulations
  24. The microstructure of magnetorheological materials characterized by means of computed X-ray microtomography
  25. Core-modified porphyrins: novel building blocks in chemistry
  26. Anticancer potential of indole derivatives: an update
  27. Novel drug design and bioinformatics: an introduction
  28. Multi-objective optimization of CCUS supply chains for European countries with higher carbon dioxide emissions
  29. Exergy analysis of an atmospheric residue desulphurization hydrotreating process for a crude oil refinery
  30. Development in nanomembrane-based filtration of emerging contaminants
  31. Supply chain optimization framework for CO2 capture, utilization, and storage in Germany
  32. Naturally occurring heterocyclic anticancer compounds
  33. Part-II- in silico drug design: application and success
  34. Advances in biopolymer composites and biomaterials for the removal of emerging contaminants
  35. Nanobiocatalysts and photocatalyst in dye degradation
  36. 3D tumor model – a platform for anticancer drug development
  37. Hydrogen production via water splitting over graphitic carbon nitride (g-C3N4 )-based photocatalysis
https://doi.org/10.1515/psr-2021-0038
Keywords for this article
antimetabolite; cytotoxic; heterocyclic scaffolds; overexpressive receptors; signal pathways

Articles in the same Issue

  1. Frontmatter
  2. Reviews
  3. Influence of lime (CaO) on low temperature leaching of some types of bauxite from Guinea
  4. Ethnobotanical survey, phytoconstituents and antibacterial investigation of Rapanea melanophloeos (L.) Mez. bark, fruit and leaf extracts
  5. Catalytic properties of supramolecular polymetallated porphyrins
  6. Lignin-based polymers
  7. Bio-based polyhydroxyalkanoates blends and composites
  8. Biodegradable poly(butylene adipate-co-terephthalate) (PBAT)
  9. Repurposing tires – alternate energy source?
  10. Theoretical investigation of the stability, reactivity, and the interaction of methyl-substituted peridinium-based ionic liquids
  11. Polymeric membranes for biomedical applications
  12. Design of locally sourced activated charcoal filter from maize cob for wastewater decontamination: an approach to fight waste with waste
  13. Synthesis of biologically active heterocyclic compounds from allenic and acetylenic nitriles and related compounds
  14. Magnetic measurement methods to probe nanoparticle–matrix interactions
  15. Health and exposure risk assessment of heavy metals in rainwater samples from selected locations in Rivers State, Nigeria
  16. Evaluation of raw, treated and effluent water quality from selected water treatment plants: a case study of Lagos Water Corporation
  17. A chemoinformatic analysis of atoms, scaffolds and functional groups in natural products
  18. Hemicyanine dyes
  19. Thermodynamics of the micellization of quaternary based cationic surfactants in triethanolamine-water media: a conductometry study
  20. Compounds isolated from hexane fraction of Alternanthera brasiliensis show synergistic activity against methicillin resistant Staphylococcus aureus
  21. Internal structures and mechanical properties of magnetic gels and suspensions
  22. SPIONs and magnetic hybrid materials: Synthesis, toxicology and biomedical applications
  23. Magnetic field controlled behavior of magnetic gels studied using particle-based simulations
  24. The microstructure of magnetorheological materials characterized by means of computed X-ray microtomography
  25. Core-modified porphyrins: novel building blocks in chemistry
  26. Anticancer potential of indole derivatives: an update
  27. Novel drug design and bioinformatics: an introduction
  28. Multi-objective optimization of CCUS supply chains for European countries with higher carbon dioxide emissions
  29. Exergy analysis of an atmospheric residue desulphurization hydrotreating process for a crude oil refinery
  30. Development in nanomembrane-based filtration of emerging contaminants
  31. Supply chain optimization framework for CO2 capture, utilization, and storage in Germany
  32. Naturally occurring heterocyclic anticancer compounds
  33. Part-II- in silico drug design: application and success
  34. Advances in biopolymer composites and biomaterials for the removal of emerging contaminants
  35. Nanobiocatalysts and photocatalyst in dye degradation
  36. 3D tumor model – a platform for anticancer drug development
  37. Hydrogen production via water splitting over graphitic carbon nitride (g-C3N4 )-based photocatalysis
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 13.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/psr-2021-0038/html
Scroll to top button